维普中文期刊产品整合服务
1篇 您的检索式:作者名="Janice Mani"
    题名 作者 年代 出处 被引量
1In vitro C ytotoxic Properties of Crude Polar Extracts of Plants Sourced from Australia显示文摘Background:Numerous commercial pharmaceuticals-including anticancer,antiviral,and antidiabetic drugs have been developed from traditional plant-derived medicines.There are approximately 25,000 species of flora occurring in Australia,which are adapted to a range of harsh environments,and hence a plethora of novel compounds are still awaiting research in the context of their medicinal properties.Objective:The current study therefore aimed to develop a systematic protocol for screening plants with potential cytotoxicity.Many studies have found polar compounds such as to be the bioactive components responsible for the therapeutic effects.Methods:The total phenolic content(TPC)and antioxidant capacity(FRAP)of methanolic extracts of selected plants was first determined.A high correlation between the TPC values and FRAP values of the plant polar extracts were evident.Cell viability of the cancer cell lines were assessed using the MTS assay.Results:Cells subjected to Pittosporum angustifolium Lodd.Extracts at concentration of 250μg/mL showed no viable cells,comparable to cisplatin(a chemotherapy medication)used as a positive control(10μg/mL).Some promising inhibitory effects were also seen with Murrya koenigii flower and leaves at concentration of 250μg/mL,with only 43.46%and 63.88%cell viability,respectively.In contrast,extracts of Citrus hystrix(leaves)and Sygyz-ium australe(stamen)showed higher percentage cell viabilities(around 82-93%)at same concentrations.The phenolic profile of P.angustifolium B extracts demonstrating greater peak intensity and dominant peaks were tentatively identified as chlorogenic acid,p-coumaric acid,caffeic acid,t-ferulic acid and rutin.Conclusion:The Australian species P.angustifolium extract was the most cytotoxic against HeLa and HT29 cells comparing to the other plant extracts tested.A HPLC profile of the P.angustifolium extract also showed an array of promising therapeutic phenolic compounds.Future work will aim to fractionate and isolate novel compounds from this species and test their bioactivity.Janice Mani Joel Johnson Holly Hosking Kerry Walsh Paul Neilsen Mani Naiker 2022Clinical Complementary Medicine and Pharmacology2022,2,1:0
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费